Adverse effects of zopiclone
[Adverse effects of zopiclone]. [Article in Norwegian]. Bramness JG, Olsen H. Comment in Tidsskr Nor Laegeforen. 1998 Aug 10;118(18):2826-7. In 1994.
National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA. National Center for Biotechnology Information, U.S.
Generate a file for use with external citation management software.
In 1996 zopiclone had a 26% share of the hypnotic market. The similarities between zopiclone and benzodiazepine hypnotics are more striking than the differences. With zopiclone there is less inhibition of psychomotor function the day after intake than with flunitrazepam. Zopiclone causes less subjective "hangover" than nitrazepam, but there is a similar inhibition of psychomotor function the day after intake, and in some cases greater addictive potential. In 1994 zopiclone (Imovane), a cyclopyrrolon, was introduced in Norway as a new kind of hypnotic. This review of relevant literature has revealed a lack of documentation on the adverse effects of zopiclone. The bulk of comparative research has been carried out with triazolam, a drug taken off the Norwegian market in 1991.